Th e main advantage of mycophenolate is the absence of toxic renal effects. Nevertheless, when it was evaluated for use as a monotherapy, higher rates of acute rejection were found.
La principal ventaja del MF es la ausencia de efectos tóxicos renales; sin embargo, cuando se evaluó para el uso como monoterapia se encontraron mayores tasas de rechazo agudo.